| 1 |
Lei T, Shi Y, Da W, Xia C, Wang H. A novel EWSR1-MYB fusion in an aggressive advanced breast adenoid cystic carcinoma with mixed classical and solid-basaloid components. Virchows Arch 2023. [PMID: 36719454 DOI: 10.1007/s00428-023-03500-1] [Reference Citation Analysis]
|
| 2 |
Sharma A, Sharma L, Nandy SK, Payal N, Yadav S, Vargas-De-La-Cruz C, Anwer MK, Khan H, Behl T, Bungau SG. Molecular Aspects and Therapeutic Implications of Herbal Compounds Targeting Different Types of Cancer. Molecules 2023;28. [PMID: 36677808 DOI: 10.3390/molecules28020750] [Reference Citation Analysis]
|
| 3 |
Michaelides I, Fest S, Pirlich M, Wichmann G, Berszin M, Wiegand S, Bohr C, Künzel J, Dietz A. Pembrolizumab und Cetuximab als therapeutische Optionen für adenoidzystische Karzinome des Kopf-Hals-Bereiches. TumorDiagnostik & Therapie 2022;43:680-684. [DOI: 10.1055/a-1956-4985] [Reference Citation Analysis]
|
| 4 |
Gaffoor N, Shetty A, Shivayogi VN, Murali N. Clinical Masquerades in Physiognomy of Sebaceous Cysts Unveiled on Histopathological Examination: a Spectrum of Cases. Indian J Surg 2022. [DOI: 10.1007/s12262-022-03629-4] [Reference Citation Analysis]
|
| 5 |
Rosa DE, Adhisty T, Dewi TS. PHARMACOLOGICAL MANAGEMENT OF ORAL LESIONS IN ADENOID CYSTIC CARCINOMA PATIENTS UNDERGOING RADIOTHERAPY. Int J App Pharm 2022. [DOI: 10.22159/ijap.2022.v14s4.op07] [Reference Citation Analysis]
|
| 6 |
Nagi T, Dabiri R, Gheit Y, Zaki A, Gan W, Torres A, Zahra T, Sule S. Rare Case of Primary Adenoid Cystic Carcinoma of the Lung With Bilateral Kidney and Liver Metastasis. J Med Cases 2022;13:551-6. [PMID: 36506756 DOI: 10.14740/jmc4016] [Reference Citation Analysis]
|
| 7 |
Keerti Kumar Y, Anil Kumar, Ajay Kumar S. A systems biology approach towards oral cancer using computational tools and techniques. Chemometrics and Intelligent Laboratory Systems 2022. [DOI: 10.1016/j.chemolab.2022.104709] [Reference Citation Analysis]
|
| 8 |
Ribeiro EA, Maleki Z. Cystic Salivary Gland Neoplasms: Diagnostic Approach With a Focus on Ancillary Studies. Advances in Anatomic Pathology 2022;Publish Ahead of Print. [DOI: 10.1097/pap.0000000000000361] [Reference Citation Analysis]
|
| 9 |
Grabenstetter A, Brogi E, Zhang H, Razavi P, Reis-Filho JS, VanZee KJ, Norton L, Wen HY. Solid-basaloid variant of adenoid cystic carcinoma of the breast with near complete response to neoadjuvant chemotherapy. NPJ Breast Cancer 2022;8:93. [PMID: 35953528 DOI: 10.1038/s41523-022-00469-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 10 |
Michaelides I, Fest S, Berszin M, Wiegand S, Bohr C, Künzel J, Dietz A, Pirlich M, Wichmann G. [Pembrolizumab and Cetuximab as therapeutic options for ACC in head and neck]. Laryngorhinootologie 2022. [PMID: 35576974 DOI: 10.1055/a-1830-8298] [Reference Citation Analysis]
|
| 11 |
Kaur K, Mehta S, Vanik S, Trivedi P, Banerjee N, Dhar H, Datta S, Karanjai S. The evolving role of molecular pathology in the diagnosis of salivary gland tumours with potential pitfalls. Eur Arch Otorhinolaryngol 2022. [PMID: 35267084 DOI: 10.1007/s00405-022-07326-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 12 |
Singaraju M, Singaraju S, Patel S, Sharma S. Adenoid cystic carcinoma: A case report and review of literature. J Oral Maxillofac Pathol 2022;26:S26-9. [PMID: 35450246 DOI: 10.4103/jomfp.jomfp_458_20] [Reference Citation Analysis]
|
| 13 |
Schwartz CJ, Brogi E, Marra A, Da Cruz Paula AF, Nanjangud GJ, da Silva EM, Patil S, Shah S, Ventura K, Razavi P, Norton L, D'alfonso T, Weigelt B, Pareja F, Reis-Filho JS, Wen HY. The clinical behavior and genomic features of the so-called adenoid cystic carcinomas of the solid variant with basaloid features. Mod Pathol 2022;35:193-201. [PMID: 34599282 DOI: 10.1038/s41379-021-00931-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
|
| 14 |
Tse DT, Latting MW, Hui JI. Epithelial Tumors of the Lacrimal Gland. Albert and Jakobiec's Principles and Practice of Ophthalmology 2022. [DOI: 10.1007/978-3-030-42634-7_68] [Reference Citation Analysis]
|
| 15 |
Feeney L, Jain Y, Beasley M, Donnelly O, Kong A, Moleron R, Nallathambi C, Rolles M, Sanghera P, Tin A, Ulahannan D, Walter HS, Webster R, Metcalf R. Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma. Cancers (Basel) 2021;13:4336. [PMID: 34503145 DOI: 10.3390/cancers13174336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 16 |
Cantù G. Adenoid cystic carcinoma. An indolent but aggressive tumour. Part A: from aetiopathogenesis to diagnosis. Acta Otorhinolaryngol Ital 2021;41:206-14. [PMID: 34264913 DOI: 10.14639/0392-100X-N1379] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 17 |
Burns W, Bird LM, Heron D, Keren B, Ramachandra D, Thiffault I, Del Viso F, Amudhavalli S, Engleman K, Parenti I, Kaiser FJ, Wierzba J, Riedhammer KM, Liptay S, Zadeh N, Porrmann J, Fischer A, Gößwein S, McLaughlin HM, Telegrafi A, Langley KG, Steet R, Louie RJ, Lyons MJ. Syndromic neurodevelopmental disorder associated with de novo variants in DDX23. Am J Med Genet A 2021. [PMID: 34050707 DOI: 10.1002/ajmg.a.62359] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 18 |
Nightingale J, Lum B, Ladwa R, Simpson F, Panizza B. Adenoid cystic carcinoma: a review of clinical features, treatment targets and advances in improving the immune response to monoclonal antibody therapy. Biochim Biophys Acta Rev Cancer 2021;1875:188523. [PMID: 33600823 DOI: 10.1016/j.bbcan.2021.188523] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 19 |
Lorini L, Ardighieri L, Bozzola A, Romani C, Bignotti E, Buglione M, Guerini A, Lombardi D, Deganello A, Tomasoni M, Bonini SA, Sigala S, Farina D, Ravanelli M, Bossi P. Prognosis and management of recurrent and/or metastatic head and neck adenoid cystic carcinoma. Oral Oncol 2021;115:105213. [PMID: 33578204 DOI: 10.1016/j.oraloncology.2021.105213] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 8.5] [Reference Citation Analysis]
|
| 20 |
Huang Z, Pan J, Chen J, Wu S, Wu T, Ye H, Zhang H, Nie X, Huang C. Multicentre clinicopathological study of adenoid cystic carcinoma: A report of 296 cases. Cancer Med 2021;10:1120-7. [PMID: 33449415 DOI: 10.1002/cam4.3707] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 21 |
Koustas E, Sarantis P, Theodorakidou M, Karamouzis MV, Theocharis S. Autophagy and salivary gland cancer: A putative target for salivary gland tumors. Tumour Biol 2020;42:1010428320980568. [PMID: 33319639 DOI: 10.1177/1010428320980568] [Reference Citation Analysis]
|
| 22 |
Xu L, Li L, Zhao S, Liu S. Recent Advances and Molecular Pathway in Salivary Adenoid Cystic Carcinoma (Review). CST 2020;15:205-14. [DOI: 10.2174/1574362414666190204124731] [Reference Citation Analysis]
|
| 23 |
Couvreur K, Celine J, Marlies B, Randal D, Philippe D, Frederic D, Sylvie R. Efficacy and toxicity of sorafenib in patients with adenoid cystic carcinoma of the head and neck: a case series of five patients. Acta Clin Belg 2020;75:362-9. [PMID: 31232197 DOI: 10.1080/17843286.2019.1633490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 24 |
Theocharis S, Tasoulas J, Masaoutis C, Kokkali S, Klijanienko J. Salivary gland cancer in the era of immunotherapy: can we exploit tumor microenvironment? Expert Opin Ther Targets 2020;24:1047-59. [PMID: 32744127 DOI: 10.1080/14728222.2020.1804863] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 25 |
Nasir N, Monroe CE, Hagerty BL, Quezado MM, Roth MJ, Schrump DS, Filie AC, Agrawal T. Adenoid cystic carcinoma of the salivary gland metastasizing to the pericardium and diaphragm: Report of a rare case. Diagn Cytopathol 2021;49:E31-5. [PMID: 32770824 DOI: 10.1002/dc.24566] [Reference Citation Analysis]
|
| 26 |
Hou H, Jia D, Yan W, Zhang X, Wang C, Li Y, Chen H, Huang W, Li Z, Zhang X. KIT/PDGFRA/KDR amplification defines a novel molecular subtype of adenoid cystic carcinoma patients who may benefit from treatment with tyrosine kinase inhibitors. Transl Cancer Res 2020;9:4703-14. [PMID: 35117834 DOI: 10.21037/tcr-20-637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 27 |
Wang Y, Han Y, Xu S, Zhang L, Zhang X, Deng J, Ye W, Liu S. Targeting EGFR Enriches Stem Cell-Like Properties in Salivary Adenoid Cystic Carcinoma by Activating the Notch1 Pathway. Cancer Manag Res 2020;12:6655-63. [PMID: 32801899 DOI: 10.2147/CMAR.S253500] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 28 |
Massé J, Truntzer C, Boidot R, Khalifa E, Pérot G, Velasco V, Mayeur L, Billerey-Larmonier C, Blanchard L, Charitansky H, Soubeyran I, Iggo R, Arnould L, MacGrogan G. Solid-type adenoid cystic carcinoma of the breast, a distinct molecular entity enriched in NOTCH and CREBBP mutations. Mod Pathol 2020;33:1041-55. [PMID: 31857685 DOI: 10.1038/s41379-019-0425-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 29 |
Wu Q, Sun W, Bu J, Xiang Y, Zhong Y. Primary Adenoid Cystic Carcinoma of the Upper Anterior Mediastinum Mimicking a Thyroid Tumor: A Case Report and Review of Literature. Front Endocrinol (Lausanne) 2020;11:242. [PMID: 32390945 DOI: 10.3389/fendo.2020.00242] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 30 |
Wang C, Wang K, Li S, Song S, Du Y, Niu R, Qian X, Peng X, Chen F. 4-Amino-2-trifluoromethyl-phenyl retinate induced differentiation of human myelodysplastic syndromes SKM-1 cell lines by up-regulating DDX23. Biomedicine & Pharmacotherapy 2020;123:109736. [DOI: 10.1016/j.biopha.2019.109736] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 31 |
Tse DT, Latting MW, Hui JI. Epithelial Tumors of the Lacrimal Gland. Albert and Jakobiec's Principles and Practice of Ophthalmology 2020. [DOI: 10.1007/978-3-319-90495-5_68-1] [Reference Citation Analysis]
|
| 32 |
Cherifi F, Rambeau A, Johnson A, Florescu C, Géry B, Babin E, Thariat J. Traitements systémiques du carcinome adénoïde kystique de la sphère ORL localement avancé ou métastatique, une revue systématique. Bulletin du Cancer 2019;106:923-38. [DOI: 10.1016/j.bulcan.2019.05.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 33 |
Abdelwahed A, Ahmed M. Rare epithelial breast cancer: surgery and adjuvant therapy. Transl Cancer Res 2019;8:S479-92. [PMID: 35117126 DOI: 10.21037/tcr.2019.05.12] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 34 |
McIntyre JB, Ko JJ, Siever J, Chan AMY, Simpson RHW, Hao D, Lau HY. MYB-NFIB gene fusions identified in archival adenoid cystic carcinoma tissue employing NanoString analysis: an exploratory study. Diagn Pathol 2019;14:78. [PMID: 31301736 DOI: 10.1186/s13000-019-0855-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 35 |
Orlando KA, Nguyen V, Raab JR, Walhart T, Weissman BE. Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities. Expert Rev Anticancer Ther 2019;19:375-91. [PMID: 30986130 DOI: 10.1080/14737140.2019.1605905] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 36 |
Lee KC, Lee JJ, Peters SM, Mandel L. Facial paralysis of unknown etiology. J Am Dent Assoc 2019;150:624-8. [PMID: 30905374 DOI: 10.1016/j.adaj.2018.11.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 37 |
Liu C, Li S, Pang F, Wu H, Chai L, Liang C, Zhang D. Autophagy‐related gene expression regulated by HIF‐1α in salivary adenoid cystic carcinoma. Oral Dis 2019;25:1076-83. [DOI: 10.1111/odi.13058] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 38 |
Jeske SS, Weissinger SE, Veit JA, Brunner C, Huber U, Theodoraki MN, Hoffmann TK, Schuler PJ, Doescher J. Treatment-induced changes of lymphocyte subsets in patients with adenoid cystic carcinoma of the head and neck. Eur Arch Otorhinolaryngol 2019;276:1465-73. [PMID: 30815724 DOI: 10.1007/s00405-019-05363-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 39 |
Liu X, Chen D, Lao X, Liang Y. The value of MYB as a prognostic marker for adenoid cystic carcinoma: Meta‐analysis. Head & Neck 2019;41:1517-24. [DOI: 10.1002/hed.25597] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 40 |
Mosconi C, de Arruda JAA, de Farias ACR, Oliveira GAQ, de Paula HM, Fonseca FP, Mesquita RA, Silva TA, Mendonça EF, Batista AC. Immune microenvironment and evasion mechanisms in adenoid cystic carcinomas of salivary glands. Oral Oncology 2019;88:95-101. [DOI: 10.1016/j.oraloncology.2018.11.028] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 41 |
Wu S, Liu J, Quan R, Han L. A rare case of nasopharyngeal adenoid cystic carcinoma treated with cetuximab-based induction therapy followed by concurrent chemoradiotherapy. Oral Oncol 2019;89:161-3. [PMID: 30594461 DOI: 10.1016/j.oraloncology.2018.12.022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 42 |
Liu X, Wu H, Huang P, Zhang F. JQ1 and PI3K inhibition synergistically reduce salivary adenoid cystic carcinoma malignancy by targeting the c-Myc and EGFR signaling pathways. J Oral Pathol Med 2019;48:43-51. [DOI: 10.1111/jop.12784] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
|
| 43 |
Warner KA, Oklejas AE, Pearson AT, Zhang Z, Wu W, Divi V, Rodriguez-Ramirez C, Castilho RM, Polverini PJ, Nör JE. UM-HACC-2A: MYB-NFIB fusion-positive human adenoid cystic carcinoma cell line. Oral Oncol 2018;87:21-8. [PMID: 30527239 DOI: 10.1016/j.oraloncology.2018.10.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 44 |
Andreasen S. Molecular features of adenoid cystic carcinoma with an emphasis on microRNA expression. APMIS 2018;126:7-57. [DOI: 10.1111/apm.12828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
|
| 45 |
Halima A, Pannunzio AM, Erstine EM, Ko JS, Bergfeld WF, Malaya RM, Frankel MB, Calhoun BC, Sturgis CD. Cutaneous Adnexal Cylindroma of Breast: Epithelial Immunoreactivities for GATA-3, Mammaglobin, and E-Cadherin Do Not Equate to a Mammary Ductal Neoplasm. Case Rep Pathol 2018;2018:4039545. [PMID: 29651355 DOI: 10.1155/2018/4039545] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 46 |
Chahal M, Pleasance E, Grewal J, Zhao E, Ng T, Chapman E, Jones MR, Shen Y, Mungall KL, Bonakdar M, Taylor GA, Ma Y, Mungall AJ, Moore RA, Lim H, Renouf D, Yip S, Jones SJM, Marra MA, Laskin J. Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making. Cold Spring Harb Mol Case Stud 2018;4:a002626. [PMID: 29610392 DOI: 10.1101/mcs.a002626] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
|
| 47 |
Goncalves PH, Heilbrun LK, Barrett MT, Kummar S, Hansen AR, Siu LL, Piekarz RL, Sukari AW, Chao J, Pilat MJ, Smith DW, Casetta L, Boerner SA, Chen A, Lenkiewicz E, Malasi S, LoRusso PM. A phase 2 study of vorinostat in locally advanced, recurrent, or metastatic adenoid cystic carcinoma. Oncotarget 2017;8:32918-29. [PMID: 28415633 DOI: 10.18632/oncotarget.16464] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 48 |
Wysocki PT, Izumchenko E, Meir J, Ha PK, Sidransky D, Brait M. Adenoid cystic carcinoma: emerging role of translocations and gene fusions. Oncotarget 2016;7:66239-54. [PMID: 27533466 DOI: 10.18632/oncotarget.11288] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 49 |
Hicks MJ. Salivary Gland, Thyroid, and Parathyroid Neoplasms: Molecular Features. Molecular Pathology Library 2018. [DOI: 10.1007/978-3-319-89626-7_11] [Reference Citation Analysis]
|
| 50 |
Kashat L, Le CH, Chiu AG. The Role of Targeted Therapy in the Management of Sinonasal Malignancies. Otolaryngol Clin North Am 2017;50:443-55. [PMID: 28314406 DOI: 10.1016/j.otc.2016.12.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
|
| 51 |
Sant DW, Tao W, Field MG, Pelaez D, Jin K, Capobianco A, Dubovy SR, Tse DT, Wang G. Whole Exome Sequencing of Lacrimal Gland Adenoid Cystic Carcinoma. Invest Ophthalmol Vis Sci 2017;58:BIO240-6. [PMID: 28820917 DOI: 10.1167/iovs.16-21097] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 52 |
Fujii K, Murase T, Beppu S, Saida K, Takino H, Masaki A, Ijichi K, Kusafuka K, Iida Y, Onitsuka T, Yatabe Y, Hanai N, Hasegawa Y, Inagaki H. MYB , MYBL1 , MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma. Histopathology 2017;71:823-34. [DOI: 10.1111/his.13281] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 6.7] [Reference Citation Analysis]
|
| 53 |
Almeida LO, Guimarães DM, Martins MD, Martins MAT, Warner KA, Nör JE, Castilho RM, Squarize CH. Unlocking the chromatin of adenoid cystic carcinomas using HDAC inhibitors sensitize cancer stem cells to cisplatin and induces tumor senescence. Stem Cell Res 2017;21:94-105. [PMID: 28426972 DOI: 10.1016/j.scr.2017.04.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
|
| 54 |
Sridhara SC, Carvalho S, Grosso AR, Gallego-paez LM, Carmo-fonseca M, de Almeida SF. Transcription Dynamics Prevent RNA-Mediated Genomic Instability through SRPK2-Dependent DDX23 Phosphorylation. Cell Reports 2017;18:334-43. [DOI: 10.1016/j.celrep.2016.12.050] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 12.2] [Reference Citation Analysis]
|
| 55 |
Hunt JL. Applications of molecular testing in surgical pathology of the head and neck. Mod Pathol 2017;30:S104-11. [PMID: 28060367 DOI: 10.1038/modpathol.2016.192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 56 |
Garber ST, Khoury L, Bell D, Schomer DF, Janku F, Mccutcheon IE. Metastatic Adenoid Cystic Carcinoma Mimicking Butterfly Glioblastoma: A Rare Presentation in the Splenium of the Corpus Callosum. World Neurosurgery 2016;95:621.e13-9. [DOI: 10.1016/j.wneu.2016.07.111] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 57 |
Escalante DA, Wang H, Fundakowski CE. Fusion proteins in head and neck neoplasms: Clinical implications, genetics, and future directions for targeting. Cancer Biol Ther 2016;17:995-1002. [PMID: 27636353 DOI: 10.1080/15384047.2016.1219823] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 58 |
Nör F, Warner KA, Zhang Z, Acasigua GA, Pearson AT, Kerk SA, Helman JI, Sant'Ana Filho M, Wang S, Nör JE. Therapeutic Inhibition of the MDM2-p53 Interaction Prevents Recurrence of Adenoid Cystic Carcinomas. Clin Cancer Res 2017;23:1036-48. [PMID: 27550999 DOI: 10.1158/1078-0432.CCR-16-1235] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
|
| 59 |
Sridharan V, Gjini E, Liao X, Chau NG, Haddad RI, Severgnini M, Hammerman P, El-Naggar A, Freeman GJ, Hodi FS, Rodig SJ, Dranoff G, Schoenfeld JD. Immune Profiling of Adenoid Cystic Carcinoma: PD-L2 Expression and Associations with Tumor-Infiltrating Lymphocytes. Cancer Immunol Res 2016;4:679-87. [PMID: 27312343 DOI: 10.1158/2326-6066.CIR-16-0031] [Cited by in Crossref: 58] [Cited by in F6Publishing: 60] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 60 |
Maximov VV, Aqeilan RI. Genetic factors conferring metastasis in osteosarcoma. Future Oncol 2016;12:1623-44. [PMID: 27072870 DOI: 10.2217/fon-2016-0014] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
|
| 61 |
Yin LX, Ha PK. Genetic alterations in salivary gland cancers. Cancer 2016;122:1822-31. [PMID: 26928905 DOI: 10.1002/cncr.29890] [Cited by in Crossref: 38] [Cited by in F6Publishing: 41] [Article Influence: 5.4] [Reference Citation Analysis]
|
| 62 |
Rettig EM, Talbot CC Jr, Sausen M, Jones S, Bishop JA, Wood LD, Tokheim C, Niknafs N, Karchin R, Fertig EJ, Wheelan SJ, Marchionni L, Considine M, Ling S, Fakhry C, Papadopoulos N, Kinzler KW, Vogelstein B, Ha PK, Agrawal N. Whole-Genome Sequencing of Salivary Gland Adenoid Cystic Carcinoma. Cancer Prev Res (Phila) 2016;9:265-74. [PMID: 26862087 DOI: 10.1158/1940-6207.CAPR-15-0316] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 8.4] [Reference Citation Analysis]
|
| 63 |
Tian Z, Li L, Zhang CY, Gu T, Li J. Differences in MYB expression and gene abnormalities further confirm that salivary cribriform basal cell tumors and adenoid cystic carcinoma are two distinct tumor entities. J Oral Pathol Med 2016;45:698-703. [PMID: 26711587 DOI: 10.1111/jop.12414] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
|
